MicroRNA-466 and microRNA-200 increase endothelial permeability in hyperglycemia by targeting Claudin-5
Open Access
- 6 July 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 29, 259-271
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of General Medical Sciences (T32 GM 139807)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK109036, R01 DK119222, R01 DK128937)
- Wayne State University
This publication has 46 references indexed in Scilit:
- Claudin-5 Controls Intercellular Barriers of Human Dermal Microvascular but Not Human Umbilical Vein Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Downregulation of Endothelial MicroRNA-200b Supports Cutaneous Wound Angiogenesis By Desilencing GATA Binding Protein 2 and Vascular Endothelial Growth Factor Receptor 2Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen SpeciesJournal of Biological Chemistry, 2009
- Vascular permeability, vascular hyperpermeability and angiogenesisAngiogenesis, 2008
- Phenotypic Heterogeneity of the EndotheliumCirculation Research, 2007
- Adaptive linear step-up procedures that control the false discovery rateBiometrika, 2006
- The tight junction: a multifunctional complexAmerican Journal of Physiology-Cell Physiology, 2004
- Size-selective loosening of the blood-brain barrier in claudin-5–deficient miceJournal of Cell Biology, 2003
- Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcersExpert Opinion on Biological Therapy, 2002